Researchers in China are reporting that they have found a way to determine which somatic cells — or differentiated body cells — that have been reprogrammed into a primordial, embryonic-like state are the most viable for therapeutic applications.
Researchers in China are reporting that they have found a way to determine which somatic cells — or differentiated body cells — that have been reprogrammed into a primordial, embryonic-like state are the most viable for therapeutic applications.